Company news

SANUWAVE Health, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company

August 22, 2023

SANUWAVE Announces Q2 2023 Financial Results

August 10, 2023

SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8: 30 AM (EDT) to Present Its Q2 2023 Financial Results

August 8, 2023

SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.

July 31, 2023

SANUWAVE Health Appoints Industry Veteran Andrew Walko as President

July 30, 2023

SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023

July 16, 2023

SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer

May 23, 2023

SANUWAVE Announces Q1 2023 Financial Results

May 11, 2023

SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9: 00 AM to Provide a Financial and Business Update

May 10, 2023

SANUWAVE Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

April 2, 2023

SANUWAVE Will Host a Live Conference Call and Webcast April 3, 2023 at 9: 00 AM to Provide a Financial and Business Update

March 29, 2023

SANUWAVE Health Commences Trading on the OTCQB Under Ticker Symbol SNWV

January 29, 2023

SANUWAVE Announces Q3 Earnings

November 13, 2022

SANUWAVE’s Energy First Technology to be Featured in 3 Clinical Posters at Upcoming 2022 Fall Symposium on Advanced Wound Care (SAWC)

October 11, 2022

SANUWAVE Announces Chief Financial Officer

August 15, 2022

SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update

August 14, 2022

SANUWAVE Closes $12 Million Capital Raise

August 7, 2022

SANUWAVE Appoints New Board Chairman

August 7, 2022

SANUWAVE® Business Update – June 2022

July 20, 2022

SANUWAVE Business Update

June 6, 2022

SANUWAVE Business Update

May 17, 2022

SANUWAVE Health Announces Patent Activity from March 2021 to March 2022

April 19, 2022

SANUWAVE Announces New Board Leadership

April 11, 2022

SANUWAVE® Business Update

April 7, 2022

SANUWAVE Health to Host Conference Call and Provide Business Update

February 27, 2022

SANUWAVE Health Provides Business Update

September 27, 2021

SANUWAVE Announces Collaboration with NASA for the Mitigation of Bacterial Biofilms Formed in the Water Processor Assembly used on International Space Station (ISS) and for Future Moon Base and Mars Colony

July 28, 2021

SANUWAVE Health Provides Updated Conference Call Information

July 12, 2021

SANUWAVE Health Presents dermaPACE System Treatment Study Results Showing Enhanced Localized Wound Tissue Oxygenation

May 26, 2021

SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed

May 20, 2021

SANUWAVE Health Announces Issuance of Eleven New Patents Bringing the Company's Total Number of Active Patents and Patent Applications to 150

May 10, 2021

SANUWAVE Health Announces $3 Million Financing

April 27, 2021

SANUWAVE® Rebrands to Reflect Evolved Wound Care Solutions

April 19, 2021

SANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership

March 29, 2021

SANUWAVE Health Announces Exclusive Distribution Agreement for Southeast Asia with Leading Taiwanese Medical Device Distributor Kingdom Brother

March 28, 2021

SANUWAVE Health Secures Customer Medical Device Financing

March 23, 2021

SANUWAVE Health Announces Distribution Agreement with Labb Solutions

March 18, 2021

SANUWAVE Health Announces Physician Office Channel Partnership with DocShop Pro

March 16, 2021

SANUWAVE Health Reports Increased Reimbursement Payments for UltraMist and dermaPACE in 2021

December 22, 2020

SANUWAVE Health Crushes Q3 Revenue Expectations; Sales Increase 895% As UltraMIST(R) Adds Accretive Punch To Already Strong Wound-Care Device Pipeline

December 2, 2020

SANUWAVE Health Reports Third Quarter 2020 Financial Results

November 16, 2020

SANUWAVE Health Significantly Strengthens Intellectual Property Portfolio with Multiple Important Patent Grants for Its Shockwave Technology

November 5, 2020

SANUWAVE Health Announces Regulatory Clearance for dermaPACE in Mexico by the Federal Commission for Protection against Sanitary Risks (COFEPRIS)

October 13, 2020

SANUWAVE Health Announces Reimbursement Coverage for BIOVANCE from Largest Medicare and Medicaid Administrator in U.S.

September 7, 2020

SANUWAVE Health Receives Approval from The National Health Surveillance Agency (ANVISA) to Market dermaPACE to Treat Chronic Wounds in Brazil

August 23, 2020

SANUWAVE Health Completes Acquisition of the Wound Care Assets of Celularity

August 9, 2020

SANUWAVE Health, Inc. Announces Successful Results of Annual Meeting of Stockholders

July 23, 2020

SANUWAVE Health Enters Into Exclusive Letter of Intent to Acquire Celularity’s UltraMIST® and Exclusive Partnership Rights for Wound Care Biologic Products

June 9, 2020

SANUWAVE Health Reports First Quarter 2020 Financial Results

May 17, 2020

SANUWAVE Health to Hold First Quarter Financial Results and Business Update Call on Monday, May 18, 2020

May 14, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 28 decks. Every deck is listed under its year.